143 related articles for article (PubMed ID: 37903564)
1. Prophylactic anticoagulation after minimally invasive hysterectomy for endometrial cancer: a cost-effectiveness analysis.
Bell S; Orellana T; Garrett A; Smith K; Kim H; Rosiello A; Rush S; Berger J; Lesnock J
Int J Gynecol Cancer; 2023 Dec; 33(12):1875-1881. PubMed ID: 37903564
[TBL] [Abstract][Full Text] [Related]
2. Incidence of venous thromboembolism after robotic-assisted hysterectomy in obese patients with endometrial cancer: do we need extended prophylaxis?
Carbajal-Mamani SL; Dideban B; Schweer D; Balavage KT; Chuang L; Wang Y; Wang S; Lee JH; Amaro B; Cardenas-Goicoechea J
J Robot Surg; 2021 Jun; 15(3):343-348. PubMed ID: 32592139
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of apixaban for prevention of venous thromboembolic events in patients after gynecologic cancer surgery.
Glickman A; Brennecke A; Tayebnejad A; Matsuo K; Guntupalli SR; Sheeder J
Gynecol Oncol; 2020 Nov; 159(2):476-482. PubMed ID: 32854972
[TBL] [Abstract][Full Text] [Related]
4. Venous thromboembolism following minimally invasive surgery among women with endometrial cancer.
Freeman AH; Barrie A; Lyon L; Littell RD; Garcia C; Conell C; Powell CB
Gynecol Oncol; 2016 Aug; 142(2):267-72. PubMed ID: 27264213
[TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness of Different Strategies for the Prevention of Venous Thromboembolism After Total Hip Replacement in China.
Yan X; Gu X; Xu Z; Lin H; Wu B
Adv Ther; 2017 Feb; 34(2):466-480. PubMed ID: 28000167
[TBL] [Abstract][Full Text] [Related]
6. Venous Thromboembolism in Minimally Invasive Compared With Open Hysterectomy for Endometrial Cancer.
Barber EL; Gehrig PA; Clarke-Pearson DL
Obstet Gynecol; 2016 Jul; 128(1):121-126. PubMed ID: 27275805
[TBL] [Abstract][Full Text] [Related]
7. A cost-effectiveness model comparing rivaroxaban and dabigatran etexilate with enoxaparin sodium as thromboprophylaxis after total hip and total knee replacement in the irish healthcare setting.
McCullagh L; Tilson L; Walsh C; Barry M
Pharmacoeconomics; 2009; 27(10):829-46. PubMed ID: 19803538
[TBL] [Abstract][Full Text] [Related]
8. A Canadian study of the cost-effectiveness of apixaban compared with enoxaparin for post-surgical venous thromboembolism prevention.
Revankar N; Patterson J; Kadambi A; Raymond V; El-Hadi W
Postgrad Med; 2013 Jul; 125(4):141-53. PubMed ID: 23933902
[TBL] [Abstract][Full Text] [Related]
9. Clinical and economic benefits of extended treatment with apixaban for the treatment and prevention of recurrent venous thromboembolism in Canada.
Quon P; Le HH; Raymond V; Mtibaa M; Moshyk A
J Med Econ; 2016 Jun; 19(6):557-67. PubMed ID: 26761644
[TBL] [Abstract][Full Text] [Related]
10. Cost Effectiveness of Apixaban and Enoxaparin for the Prevention of Venous Thromboembolism After Total Knee Replacement in China.
Yan X; Gu X; Zhou L; Lin H; Wu B
Clin Drug Investig; 2016 Dec; 36(12):1001-1010. PubMed ID: 27581246
[TBL] [Abstract][Full Text] [Related]
11. Venous Thromboembolism in Patients Receiving Extended Pharmacologic Prophylaxis After Robotic Surgery for Endometrial Cancer.
Kim JS; Mills KA; Fehniger J; Liao C; Hurteau JA; Kirschner CV; Lee NK; Rodriguez GC; Yamada SD; Diaz Moore ES; Tenney ME
Int J Gynecol Cancer; 2017 Oct; 27(8):1774-1782. PubMed ID: 28708786
[TBL] [Abstract][Full Text] [Related]
12. Systematic review of randomized controlled trials of new anticoagulants for venous thromboembolism prophylaxis in major orthopedic surgeries, compared with enoxaparin.
Yoshida Rde A; Yoshida WB; Maffei FH; El Dib R; Nunes R; Rollo HA
Ann Vasc Surg; 2013 Apr; 27(3):355-69. PubMed ID: 23351997
[TBL] [Abstract][Full Text] [Related]
13. Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal.
Stevenson M; Scope A; Holmes M; Rees A; Kaltenthaler E
Health Technol Assess; 2009 Oct; 13 Suppl 3():43-8. PubMed ID: 19846028
[TBL] [Abstract][Full Text] [Related]
14. Lymphadenectomy is associated with an increased risk of postoperative venous thromboembolism in early stage endometrial cancer.
Latif N; Oh J; Brensinger C; Morgan M; Lin LL; Cory L; Ko EM
Gynecol Oncol; 2021 Apr; 161(1):130-134. PubMed ID: 33551203
[TBL] [Abstract][Full Text] [Related]
15. Results of an economic model to assess the cost-effectiveness of enoxaparin, a low-molecular-weight heparin, versus warfarin for the prophylaxis of deep vein thrombosis and associated long-term complications in total hip replacement surgery in the United States.
Botteman MF; Caprini J; Stephens JM; Nadipelli V; Bell CF; Pashos CL; Cohen AT
Clin Ther; 2002 Nov; 24(11):1960-86; discussion 1938. PubMed ID: 12501885
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of rivaroxaban compared with enoxaparin plus a vitamin K antagonist for the treatment of venous thromboembolism.
Lefebvre P; Coleman CI; Bookhart BK; Wang ST; Mody SH; Tran KN; Zhuo DY; Huynh L; Nutescu EA
J Med Econ; 2014 Jan; 17(1):52-64. PubMed ID: 24156243
[TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness of rivaroxaban versus enoxaparin for prevention of post-surgical venous thromboembolism from a U.S. payer's perspective.
Duran A; Sengupta N; Diamantopoulos A; Forster F; Kwong L; Lees M
Pharmacoeconomics; 2012 Feb; 30(2):87-101. PubMed ID: 22187932
[TBL] [Abstract][Full Text] [Related]
18. Extended Venous Thromboembolism Prophylaxis after Robotic Staging for Endometrial Cancer.
Palmieri A; Hicks V; Aikman N; Borowsky M; Haggerty A; ElSahwi K
South Med J; 2023 Oct; 116(10):790-794. PubMed ID: 37788812
[TBL] [Abstract][Full Text] [Related]
19. Extended dalteparin prophylaxis for venous thromboembolic events: cost-utility analysis in patients undergoing major orthopedic surgery.
Dranitsaris G; Stumpo C; Smith R; Bartle W
Am J Cardiovasc Drugs; 2009; 9(1):45-58. PubMed ID: 19178131
[TBL] [Abstract][Full Text] [Related]
20. Extended pharmacologic thromboprophylaxis in oncologic liver surgery is safe and effective.
Kim BJ; Day RW; Davis CH; Narula N; Kroll MH; Tzeng CWD; Aloia TA
J Thromb Haemost; 2017 Nov; 15(11):2158-2164. PubMed ID: 28846822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
